— Know what they know.
Not Investment Advice

PRTK NASDAQ

Paratek Pharmaceuticals, Inc.
1W: +0.0% 1M: +1.4% 3M: +0.9% 1Y: -10.1% 3Y: -60.0% 5Y: -76.4%
$2.23
Last traded 2023-09-29 — delisted
NASDAQ · Healthcare · Biotechnology · $127.8M mcap · 50M float · 1.26% daily turnover

📊 Key Metrics

TTM
$168M
Revenue
+66.0% YoY
$-67M
Net Income
+25.8% YoY
$-23M
Free Cash Flow
+14.3% YoY
88.5%
Gross Margin
-24.7%
Op. Margin
-38.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.3%
ROA-43.4%
ROIC-224.1%

Valuation

P/E-1.9
P/B-0.7
EV/EBITDA-7.9

Leverage

Debt/Equity-1.29
Current Ratio0.52
Interest Cov.-2.3x

Quality Scores

Piotroski F4/9
Altman Z-9.69
Beneish M-3.52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms